"Much-Needed Win": Novo Shares Jump Most In Nearly Two Years After US Approval Of Wegovy Obesity Pill
“Much-Needed Win”: Novo Shares Jump Most In Nearly Two Years After US Approval Of Wegovy Obesity Pill Novo Nordisk shares in Europe jumped the most in nearly two years after the U.S. FDA approved the Wegovy pill, a once-daily 25 mg oral semaglutide, for long-term weight loss, weight maintenance, and reduction of major adverse cardiovascular […]
Discuss on Nostr!
Nostr Note ID note1g4nmjam4ctxq9pketjrx0aaqc9jj24peg5zqx7ms6smw3fwc8h4sywaxfa Open on Primal.net Open on Snort.social Open on Iris.to Open on Coracle.social
New to Nostr?
Create an account now & join the conversation!
Promote it on DissentWatch!
- To advertise this post for $0.02 per visit send bitcoins to the address below
- The post will be promoted daily via social media & our "Featured News" display in multiple places
- You can add more anytime
- Ranking order in the Featured News box is based on the balance remaining
Received: 0 mBTC (0.00 USD)
Spent: 0 mBTC (0.00 USD)
Balance: 0 mBTC (0.00 USD)
The amounts above may be lagging behind. If you just sent a payment click below to get more up to date results and push the post to the "Featured News" box faster.